In The Spotlight


handshake-dec13.jpg 2019 saw more than 25 acquisition deals being executed in the biotech sector, of which 14 were billion-dollar deals. Bristol-Myers Squibb (BMY) acquiring Celgene for $74 billion in January remains the most expensive acquisition of this year.

Shares of MEDNAX Inc. (MD) have climbed over 5% in the last 4 trading days.

bankipo-dec11.jpg 2020 will be upon us soon. It's time to take stock of some of the US healthcare IPOs that rewarded investors in 2019.

gritstone-dec11.jpg Shares of Gritstone Oncology Inc. (GRTS), a clinical-stage biotechnology company, have rallied 26 percent so far this month in the run-up to the presentation at the European Society for Medical Oncology's Immuno-Oncology Congress (ESMO-IO) on December 12, 2019.

gmed-dec09.jpg Shares of Globus Medical Inc. (GMED) closed at an all-time high of $57.18 on Friday (Dec.6), and are up 32 percent year-to-date.

bhc1-dec05.jpg Shares of Bausch Health Companies Inc. (BHC) (BHC.TO), which are up 55 percent year-to-date, closed at an all-time high of $28.68 yesterday.

kadmon-dec02.jpg Shares of Kadmon Holdings Inc. (KDMN) have gained an impressive 53% over the last 1 month.

Can-Fite BioPharma Ltd. (CANF), a biotechnology company developing drugs that address cancer, liver and inflammatory diseases, looks forward to several milestones in 2020.

Shares of Inspire Medical Systems Inc. (INSP) hit a new high in intraday trading today and are currently at $71.

globalcordbloodcorp1-nov27.jpg Shares of Global Cord Blood Corp. (CO) are down nearly 37% from their 52-week high of $7.73 recorded on March 1, 2019.

baduaxbio-nov27.jpg Baudax Bio Inc., a spinoff from Recro Pharma Inc (REPH), began trading on the NASDAQ Capital Market under the ticker symbol "BXRX" on November 22, 2019. The shares have gained more than 50 percent over the last three trading days.

emergent-nov22.jpg Shares of Emergent BioSolutions Inc (EBS) are down 26% from their 52-week high of $73.89 recorded on December 3, 2018, and stock may be worth a look now.

Zoetis is an animal health company - catering to the health of cattle, pigs, poultry, sheep, fish, dogs, cats and horses. The Company has roughly 300 product lines, which are sold in more than 100 countries.

Shares of Myovant Sciences Ltd. (MYOV) have gained more than 130% over the last 5 trading days, thanks to HERO, the Company's phase III study of once-daily, oral Relugolix in men with advanced prostate cancer.

avadel-nov25.jpg Shares of Avadel Pharmaceuticals plc (AVDL) are up an impressive 129 percent year-to-date.

Follow RTT